Lamotrigine caught marketing approval for combination therapy to refractory epileptics of whom the other antiepileptic drugs were not effective in December, 2008 and for maintenance therapy to the bipolar disorder in July, 2011. In our hospital, lamotrigine has been adopted since September, 2009. We investigated for 177 patients (male 51, female 126) who were prescribed lamotrigine from July1st, 2011 to July 31st, 2014. The mean age of the patients was 45.5. Of 177 patients, the number of the bipolar disorder was 96 (bipolarⅠ32, Ⅱ64). The discontinuation of the prescription was 80 cases. The reasons were: ineffective in 28 patients, side effects in 25 and so on, containing rash in 22 patients. Of 97 continuing cases, lamotrigine was estimated as effective in 76 cases. Lamotrigine was found to be effective for depressive state and maintenance therapy of bipolar disorder.
View full abstract